Story thread · 3 reports / 3 sources

Gland Pharma shares rally 10% post Q1 results: Highest and lowest target prices

businesstoday.in · 16h

Gland Pharma target prices: Ambit Capital suggested a target of Rs 1,940 on the stock, the lowest on the Street so far. Jefferies' target of Rs 3,350 on Gland Pharma is the highest. Nomura sees the stock at Rs 3,330.

First report: Gland Pharma eyes $100m revenue with new deal economictimes.indiatimes.com, 2d

The coverage

  1. Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue

    thehindu.com · 1d

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.